Abstract:Celastrol, a plant-derived triterpene, has neuroprotective benefit in the models of neurodegenerative disorders that are characterized by overproduction of reactive oxygen species (ROS). Recently, we have reported that cadmium (Cd) activates c-Jun N-terminal kinase (JNK) pathway leading to neuronal cell death by inducing ROS inactivation of protein phosphatase 5 (PP5), and celastrol prevents Cd-activated JNK pathway against neuronal apoptosis. Therefore, we hypothesized that celastrol could hinder Cd induction of ROS-dependent PP5-JNK signaling pathway from apoptosis in neuronal cells. Here, we show that celastrol attenuated Cd-induced expression of NADPH oxidase 2 (NOX2) and its regulatory proteins (p22(phox), p40(phox), p47(phox), p67(phox), and Rac1), as well as the generation of ROS in PC12 cells and primary neurons. Also, N-acetyl-l-cysteine, a ROS scavenger, potentiated celastrol's inhibition of the events in the cells triggered by Cd, implying neuroprotection by celastrol via blocking Cd-evoked NOX2-derived ROS. Further research revealed that celastrol was involved in the regulation of PP5 inactivation and JNK/c-Jun activation induced by Cd, as celastrol prevented Cd from reducing PP5 expression, and over-expression of wild-type PP5 or dominant negative c-Jun strengthened celastrol's inhibition of Cd-induced phosphorylation of JNK and/or c-Jun, as well as apoptosis in neuronal cells. Of importance, inhibiting NOX2 with apocynin or silencing NOX2 by RNA interference enhanced the inhibitory effects of celastrol on Cd-induced inactivation of PP5, activation of JNK/c-Jun, ROS, and apoptosis in the cells. Furthermore, we noticed that expression of wild-type PP5 or dominant negative c-Jun, or pretreatment with JNK inhibitor SP600125 reinforced celastrol's suppression of Cd-induced NOX2 and its regulatory proteins, and consequential ROS in neuronal cells. These findings indicate that celastrol ameliorates Cd-induced neuronal apoptosis via targeting NOX2-derived ROS-dependent PP5-JNK signaling pathway. Our data highlight a beneficial role of celastrol in the prevention of Cd-induced oxidative stress and neurodegenerative diseases.

Resveratrol prevents cadmium activation of Erk1/2 and JNK pathways from neuronal cell death via protein phosphatases 2A and 5

Neuroprotection of resveratrol against cadmium-poisoning acts through dual inhibition of mTORC1/2 signaling

Resveratrol Protects Against Cadmium-Induced Cerebrum Toxicity Through Modifications of the Cytochrome P450 Enzyme System in Microsomes.

Ameliorative effects of resveratrol against cadmium-induced nephrotoxicity <i>via</i> modulating nuclear xenobiotic receptor response and PINK1/Parkin-mediated Mitophagy

Celastrol Prevents Cadmium‐induced Neuronal Cell Death Via Targeting JNK and PTEN‐Akt/mTOR Network

Resveratrol Rescues Cadmium-Induced Mitochondrial Injury by Enhancing Transcriptional Regulation of PGC-1α and SOD2 Via the Sirt3/FoxO3a Pathway in TCMK-1 Cells.

Celastrol prevents cadmium-induced neuronal cell death by blocking mitochondrial ROS inactivation of AMPK and activation of mTOR pathway.

Resveratrol protects MC3T3-E1 cells against cadmium-induced suppression of osteogenic differentiation by modulating the ERK1/2 and JNK pathways

Rapamycin Ameliorates Cadmium-Induced Activation of MAPK Pathway and Neuronal Apoptosis by Preventing Mitochondrial ROS Inactivation of PP2A

Resveratrol Protects PC12 Cell against 6-OHDA Damage via CXCR4 Signaling Pathway

CaMKII is involved in cadmium activation of MAPK and mTOR pathways leading to neuronal cell death.

Celastrol ameliorates Cd-induced neuronal apoptosis by targeting NOX2-derived ROS-dependent PP5-JNK signaling pathway.

Cadmium induction of reactive oxygen species activates the mTOR pathway, leading to neuronal cell death.

Metformin Attenuates Cadmium-Induced Neuronal Apoptosis in Vitro Via Blocking ROS-dependent PP5/AMPK-JNK Signaling Pathway

Cadmium induces mitochondrial ROS inactivation of XIAP pathway leading to apoptosis in neuronal cells

Resveratrol ameliorates toxic effects of cadmium on placental development in mouse placenta and human trophoblast cells

Cadmium Impairs Autophagy Leading to Apoptosis by Ca2+-Dependent Activation of JNK Signaling Pathway in Neuronal Cells

Rapamycin inhibits Erk1/2-mediated neuronal apoptosis caused by cadmium.

Rapamycin Prevents Cadmium-Induced Neuronal Cell Death Via Targeting Both Mtorc1 and Mtorc2 Pathways

Celastrol Attenuates Cadmium-Induced Neuronal Apoptosis Via Inhibiting Ca2+-Camkii-Dependent Akt/Mtor Pathway

Luteolin prevents cadmium-induced PC12 cell death by suppressing the Akt/mTOR signaling pathway